Back to Search
Start Over
Dopamine-induced arrestin recruitment and desensitization of the dopamine D4 receptor is regulated by G protein-coupled receptor kinase-2.
- Source :
- Frontiers in Pharmacology; 1/27/2023, Vol. 14, p1-10, 10p, 4 Graphs
- Publication Year :
- 2023
-
Abstract
- The dopamine D<subscript>4</subscript> receptor (D<subscript>4</subscript>R) is expressed in the retina, prefrontal cortex, and autonomic nervous system and has been implicated in attention deficit hyperactivity disorder (ADHD), substance use disorders, and erectile dysfunction. D<subscript>4</subscript>R has also been investigated as a target for antipsychotics due to its high affinity for clozapine. As opposed to the closely related dopamine D<subscript>2</subscript> receptor (D2R), dopamine-induced arrestin recruitment and desensitization at the D<subscript>4</subscript>R have not been studied in detail. Indeed, some earlier investigations could not detect arrestin recruitment and desensitization of this receptor upon its activation by agonist. Here, we used a novel nanoluciferase complementation assay to study dopamine-induced recruitment of β-arrestin2 (βarr2; also known as arrestin3) and G protein-coupled receptor kinase-2 (GRK2) to the D<subscript>4</subscript>R in HEK293T cells. We also studied desensitization of D<subscript>4</subscript>R-evoked G protein-coupled inward rectifier potassium (GIRK; also known as Kir3) current responses in Xenopus oocytes. Furthermore, the effect of c-oexpression of GRK2 on βarr2 recruitment and GIRK response desensitization was examined. The results suggest that co-expression of GRK2 enhanced the potency of dopamine to induce βarr2 recruitment to the D<subscript>4</subscript>R and accelerated the rate of desensitization of D<subscript>4</subscript>R-evoked GIRK responses. The present study reveals new details about the regulation of arrestin recruitment to the D<subscript>4</subscript>R and thus increases our understanding of the signaling and desensitization of this receptor. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 16639812
- Volume :
- 14
- Database :
- Complementary Index
- Journal :
- Frontiers in Pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 163270614
- Full Text :
- https://doi.org/10.3389/fphar.2023.1087171